Group 1 - Innotech's stock price increased by 5.14% to 33.73 CNY per share, with a trading volume of 105 million CNY and a turnover rate of 4.57%, resulting in a total market capitalization of 4.62 billion CNY [1] - Innotech, established on February 6, 2006, and listed on July 28, 2022, specializes in the research, production, and sales of POCT rapid diagnostic products, with revenue composition primarily from respiratory series (96.49%), other reagents (2.99%), and preconception care series (0.51%) [1] Group 2 - Among Innotech's top ten circulating shareholders, a fund under Yongying Fund ranks first, while the Medical Device ETF (159883) entered the top ten shareholders in Q3, holding 498,000 shares, which is 0.72% of the circulating shares, with an estimated floating profit of approximately 821,600 CNY [2] - The Medical Device ETF (159883) was established on April 22, 2021, with a latest scale of 4.73 billion CNY, yielding 7.59% this year, ranking 3856 out of 4216 in its category, and 2.05% over the past year, ranking 3647 out of 3913, while it has a cumulative loss of 47.83% since inception [2]
英诺特股价涨5.14%,永赢基金旗下1只基金位居十大流通股东,持有49.8万股浮盈赚取82.16万元